Tredje AP-fonden’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

Tredje AP-fonden’s Portfolio TCON Stock Details TCON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-1,234	Closed	-$2.88M	–	300
2015 Q2	$2.88M	Buy	+1,234	New	+$2.9M	0.23%	114

Other funds holding TCON

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return

J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Tredje AP-fonden's TCON Position: Q3 2015 in Review

Tredje AP-fonden sold out of TRACON Pharmaceuticals, Inc. Common Stock (TCON) in Q3 2015, closing a stake of 1,234 shares — an estimated $2.88M sold.

Tredje AP-fonden first reported a position in TCON in Q2 2015 and held it in 1 quarter. The position peaked at $2.88M in Q2 2015. 27 funds tracked by Wall St. Rank hold TCON as of Q3 2015.

Tredje AP-fonden reported no remaining TRACON Pharmaceuticals, Inc. Common Stock position as of Q3 2015 after selling out during the quarter.
Tredje AP-fonden sold 1,234 TRACON Pharmaceuticals, Inc. Common Stock shares in Q3 2015, an estimated $2.88M.
Tredje AP-fonden first reported a position in TRACON Pharmaceuticals, Inc. Common Stock in Q2 2015 and held it in 1 quarter.
Tredje AP-fonden's TRACON Pharmaceuticals, Inc. Common Stock position peaked at $2.88M in Q2 2015.
27 funds tracked by Wall St. Rank held TRACON Pharmaceuticals, Inc. Common Stock as of Q3 2015.

Based on Tredje AP-fonden's 13F filing for Q3 2015, filed 10 Nov 2015.